IL-1β and IL-10 gene polymorphisms in women with gestational diabetes

References

• Kim C. Gestational diabetes: risks, management, and treatment options. Int J Womens Health. 2010;2:339–351.
   PubMedGoogle Scholar
• Barbour LA, McCurdy CE, Hernandez TL, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30(Suppl. 2):S112–S119.
   PubMed Web of Science ®Google Scholar
• Hrolfsdottir L, Schalkwijk CG, Birgisdottir BE, et al. Maternal diet, gestational weight gain, and inflammatory markers during pregnancy. Obesity (Silver Spring). 2016;24(10):2133–2139.
   PubMed Web of Science ®Google Scholar
• Kalagiri RR, Carder T, Choudhury S, et al. Inflammation in complicated pregnancy and its outcome. Am J Perinatol. 2016;33(14):1337–1356.
   PubMed Web of Science ®Google Scholar
• Wedekind L, Belkacemi L. Altered cytokine network in gestational diabetes mellitus affects maternal insulin and placental–fetal development. J Diabetes Complications. 2016;30(7):1393–1400.
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Visser GH, Krithinakis K, et al. First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation. Metabolism. 2016;65(3):131–137.
   PubMed Web of Science ®Google Scholar
• Mordwinkin NM, Ouzounian JG, Yedigarova L, et al. Alteration of endothelial function markers in women with gestational diabetes and their fetuses. J Matern Fetal Neonatal Med. 2013;26(5):507–512.
   PubMed Web of Science ®Google Scholar
• Gomes JS, Minasi LB, da Cruz AD, et al. Identification of trends in scientific publications related to genetic polymorphisms in gestational diabetes mellitus. Genet Mol Res. 2016;15(2):7672.
   Web of Science ®Google Scholar
• Shu Y, Chen Y, Luo H, et al. The roles of IL-10 gene polymorphisms in diabetes mellitus and their associated complications: a meta-analysis. Horm Metab Res. 2018;50(11):811–815.
   PubMed Web of Science ®Google Scholar
• Vargas-Alarcón G, Cruz-López M, Valladares A, et al. The interleukin-1β-511 T > C (rs16944) gene polymorphism is associated with risk of developing silent myocardial ischemia in diabetic patients. Immunol Lett. 2015;168(1):7–12.
   PubMed Web of Science ®Google Scholar
• Tayel SI, Fouda EAM, Elshayeb EI, et al. Biochemical and molecular study on interleukin-1β gene expression and relation of single nucleotide polymorphism in promoter region with type 2 diabetes mellitus. J Cell Biochem. 2018;119(7):5343–5349.
   PubMed Web of Science ®Google Scholar
• Jiménez-Sousa MÁ, Medrano LM, Liu P, et al. IL-1b rs16944 polymorphism is related to septic shock and death. Eur J Clin Invest. 2017;47(1):53–62.
   PubMed Web of Science ®Google Scholar
• Mazurek-Mochol M, Dembowska E, Malinowski D, et al. IL-1ß rs1143634 and rs16944 polymorphisms in patients with periodontal disease. Arch Oral Biol. 2019;98:47–51.
   PubMed Web of Science ®Google Scholar
• Pawlik A, Teler J, Maciejewska A, et al. Adiponectin and leptin gene polymorphisms in women with gestational diabetes mellitus. J Assist Reprod Genet. 2017;34(4):511–516.
   PubMed Web of Science ®Google Scholar
• Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123(6):1793–1803.
   PubMed Web of Science ®Google Scholar
• Patel R, Dwivedi M, Mansuri MS, et al. Association of neuropeptide-Y (NPY) and interleukin-1beta (IL1B), genotype–phenotype correlation and plasma lipids with type-II diabetes. PLoS One. 2016;11(10):e0164437.
   PubMed Web of Science ®Google Scholar
• Luotola K, Pääkkönen R, Alanne M, et al. Association of variation in the interleukin-1 gene family with diabetes and glucose homeostasis. J Clin Endocrinol Metab. 2009;94(11):4575–4583.
   PubMed Web of Science ®Google Scholar
• Maintinguer Norde M, Oki E, Ferreira Carioca AA, et al. Influence of IL1B, IL6 and IL10 gene variants and plasma fatty acid interaction on metabolic syndrome risk in a cross-sectional population-based study. Clin Nutr. 2018;37(2):659–666.
   PubMed Web of Science ®Google Scholar
• Posadas-Sánchez R, Angeles-Martínez J, Pérez-Hernández N, et al. The IL-10-1082 (rs1800896) G allele is associated with a decreased risk of developing premature coronary artery disease and some IL-10 polymorphisms were associated with clinical and metabolic parameters. The GEA study. Cytokine. 2018;106:12–18.
   PubMed Web of Science ®Google Scholar
• Forte GI, Pilato G, Vaccarino L, et al. Risk profiles in type 2 diabetes (metabolic syndrome): integration of IL-10 polymorphisms and laboratory parameters to identify vascular damages related complications. CPD. 2010;16(7):898–903.
   Web of Science ®Google Scholar
• Montazeri S, Nalliah S, Radhakrishnan AK. Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? Hereditas. 2010;147(2):94–102.
   PubMed Web of Science ®Google Scholar
• Kim JO, Lee WS, Lee BE, et al. Interleukin-1beta −511T > C genetic variant contributes to recurrent pregnancy loss risk and peripheral natural killer cell proportion. Fertil Steril. 2014;102(1):206–212.e5.
   PubMed Web of Science ®Google Scholar
• Kalish RB, Vardhana S, Gupta M, et al. Interleukin-4 and -10 gene polymorphisms and spontaneous preterm birth in multifetal gestations. Am J Obstet Gynecol. 2004;190(3):702–706.
   PubMed Web of Science ®Google Scholar
• Sowmya S, Sri Manjari K, Ramaiah A, et al. Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia. Clin Exp Immunol. 2014;178(2):334–341.
   PubMed Web of Science ®Google Scholar
• Wujcicka WI, Wilczyński JS, Nowakowska DE. Association of SNPs from IL1A, IL1B, and IL6 genes with human cytomegalovirus infection among pregnant women. Viral Immunol. 2017;30(4):288–297.
   PubMed Web of Science ®Google Scholar
• Yılmaz Y, Verdi H, Taneri A, et al. Maternal–fetal proinflammatory cytokine gene polymorphism and preterm birth. DNA Cell Biol. 2012;31(1):92–97.
   PubMed Web of Science ®Google Scholar
• Pantham P, Aye IL, Powell TL. Inflammation in maternal obesity and gestational diabetes mellitus. Placenta. 2015;36(7):709–715.
   PubMed Web of Science ®Google Scholar
• Roca-Rodríguez MDM, López-Tinoco C, Fernández-Deudero Á, et al. Unfavorable cytokine and adhesion molecule profiles during and after pregnancy, in women with gestational diabetes mellitus. Endocrinol Diabetes Nutr. 2017;64(1):18–25.
   PubMed Web of Science ®Google Scholar
• de Castro J, Sevillano J, Marciniak J, et al. Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy. Endocrinology. 2011;152(11):4094–4105.
   PubMed Web of Science ®Google Scholar
• Vitoratos N, Valsamakis G, Mastorakos G, et al. Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes. Hormones (Athens). 2008;7(3):230–236.
   PubMedGoogle Scholar
• Aye IL, Jansson T, Powell TL. Interleukin-1β inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts. Mol Cell Endocrinol. 2013;381(1–2):46–55.
   PubMed Web of Science ®Google Scholar
• Jager J, Grémeaux T, Cormont M, et al. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology. 2007;148(1):241–251.
   PubMed Web of Science ®Google Scholar
• Stienstra R, Joosten LA, Koenen T, et al. The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010;12(6):593–605.
   PubMed Web of Science ®Google Scholar
• Gao D, Madi M, Ding C, et al. Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes. Am J Physiol Endocrinol Metab. 2014;307(3):E289–E304.
   PubMed Web of Science ®Google Scholar
• Katra P, Dereke J, Nilsson C, et al. Plasma levels of the interleukin-1-receptor antagonist are lower in women with gestational diabetes mellitus and are particularly associated with postpartum development of type 2 diabetes. PLoS One. 2016;11(5):e0155701.
   PubMed Web of Science ®Google Scholar
• Handa M, Vanegas S, Maddux BA, et al. XOMA 052, an anti-IL-1β monoclonal antibody, prevents IL-1β-mediated insulin resistance in 3T3-L1 adipocytes. Obesity (Silver Spring). 2013;21(2):306–309.
   PubMed Web of Science ®Google Scholar